Ming Yan Cytek Biosciences, Inc. (CTKB) insider trading activity

Ming Yan is CHIEF TECHNOLOGY OFFICER of Cytek Biosciences, Inc.. Currently has a direct ownership of 6.02 Million shares of CTKB, which is worth approximately $38.5 Million. The most recent transaction as insider was on Nov 18, 2024, when has been sold 3,622 shares (Common Stock) at a price of $6.03 per share, resulting in proceeds of $21,840. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.02M

0.19% 3M change

0.39% 12M change

Total Value Held $38.5 Million

Ming Yan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2024	SELL Payment of exercise price or tax liability	$21,840 $6.03 p/Share	3,622 Reduced 0.06%	6,018,322 Common Stock
Nov 18 2024	BUY Exercise of conversion of derivative security	-	14,869 Added 0.25%	6,019,668 Common Stock
Aug 19 2024	SELL Payment of exercise price or tax liability	$20,632 $5.53 p/Share	3,731 Reduced 0.06%	6,007,075 Common Stock
Aug 19 2024	BUY Exercise of conversion of derivative security	-	14,869 Added 0.25%	6,008,421 Common Stock
May 20 2024	SELL Payment of exercise price or tax liability	$18,696 $5.96 p/Share	3,137 Reduced 0.05%	5,995,937 Common Stock
May 20 2024	BUY Exercise of conversion of derivative security	-	10,572 Added 0.18%	5,997,030 Common Stock
Apr 19 2024	SELL Open market or private sale	$117,400 $5.87 p/Share	20,000 Reduced 0.33%	5,988,502 Common Stock
Apr 09 2024	SELL Open market or private sale	$13,319 $7.01 p/Share	1,900 Reduced 0.03%	6,008,502 Common Stock
Mar 19 2024	SELL Open market or private sale	$134,200 $6.71 p/Share	20,000 Reduced 0.33%	6,010,402 Common Stock
Mar 18 2024	SELL Open market or private sale	$135,400 $6.77 p/Share	20,000 Reduced 0.33%	6,030,402 Common Stock
Mar 11 2024	SELL Payment of exercise price or tax liability	$21,017 $7.22 p/Share	2,911 Reduced 0.05%	6,050,402 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	-	9,817 Added 0.16%	6,053,313 Common Stock
Feb 20 2024	SELL Payment of exercise price or tax liability	$4,927 $8.38 p/Share	588 Reduced 0.01%	6,043,496 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	-	1,981 Added 0.03%	6,044,084 Common Stock
Dec 19 2023	SELL Open market or private sale	$188,600 $9.43 p/Share	20,000 Reduced 0.33%	6,042,103 Common Stock
Nov 20 2023	SELL Open market or private sale	$120,600 $6.03 p/Share	20,000 Reduced 0.26%	7,762,103 Common Stock
Nov 18 2023	SELL Payment of exercise price or tax liability	$19,153 $5.98 p/Share	3,203 Reduced 0.04%	7,782,103 Common Stock
Nov 18 2023	BUY Exercise of conversion of derivative security	-	9,344 Added 0.12%	7,784,534 Common Stock
Nov 14 2023	SELL Bona fide gift	-	1,700,000 Reduced 21.9%	6,062,103 Common Stock
Oct 19 2023	SELL Open market or private sale	$96,000 $4.8 p/Share	20,000 Reduced 0.26%	7,775,962 Common Stock
Sep 19 2023	SELL Open market or private sale	$129,800 $6.49 p/Share	20,000 Reduced 0.26%	7,795,962 Common Stock
Aug 21 2023	SELL Open market or private sale	$161,400 $8.07 p/Share	20,000 Reduced 0.26%	7,815,962 Common Stock
Aug 18 2023	SELL Payment of exercise price or tax liability	$30,794 $8.46 p/Share	3,640 Reduced 0.05%	7,835,962 Common Stock
Aug 18 2023	BUY Exercise of conversion of derivative security	-	9,344 Added 0.12%	7,838,830 Common Stock
Jul 19 2023	SELL Open market or private sale	$175,200 $8.76 p/Share	20,000 Reduced 0.25%	7,830,258 Common Stock

Ming Yan

CHIEF TECHNOLOGY OFFICER

Fremont, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Value

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cytek Biosciences, Inc.

Track Activities on CTKB

Account